Cargando…

OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML

BACKGROUND: Acute myeloid leukemia (AML) is a malignant clonal disease of the myeloid hematopoietic system. Clinically, standard treatment options include conventional chemotherapy as well as hematopoietic stem cell transplantation. Among them, chemotherapy has a remission rate of 60% to 80% and nea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xuan, Li, Ying, Yang, Yan, Zhuang, Wanchuan, Chai, Xingxing, Gong, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977544/
https://www.ncbi.nlm.nih.gov/pubmed/36873740
http://dx.doi.org/10.1155/2023/6017852

Ejemplares similares